Mikusu India Private Ltd buys 5,040 shares in Daikaffil Chemicals, stake now 49.40%

What Daikaffil Chemicals disclosed

On 16 June 2026, BSE received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on behalf of Daikaffil Chemicals India Ltd (Scrip Code 530825). The disclosure was submitted by Mikusu India Private Limited, a promoter of Daikaffil Chemicals, to inform the market of an open‑market purchase of equity shares.

The filing states that Mikusu India Private Ltd acquired 5,040 equity shares of Daikaffil Chemicals on 15 June 2026. The acquisition was executed through the open market on BSE and is reported in the standard format prescribed by SEBI for substantial share‑acquisition disclosures.

Details of the share acquisition

• Acquirer: Mikusu India Private Limited (Director: Raghuram K Shetty, DIN 00038703)
• Target company: Daikaffil Chemicals India Ltd
• Number of shares acquired: 5,040 equity shares
• Mode of acquisition: Open‑market purchase on BSE
• Date of acquisition: 15 June 2026
• Equity share capital of target: Rs 6 crore, comprising 60 lakh shares of Rs 10 each (unchanged before and after the transaction)
• Regulatory basis: Disclosure under SEBI Regulation 29(2) – required when a promoter or any acquirer crosses the 1 % threshold or when there is a change in shareholding that may affect control.

The filing also confirms that the acquirer belongs to the promoter group of Daikaffil Chemicals, which is relevant for assessing any change‑of‑control implications.

Shareholding before and after the transaction

The additional 5,040 shares represent a 0.08 % increase in both the total and diluted share‑voting capital of Daikaffil Chemicals.

Key facts at a glance

Why this matters for investors

The disclosure satisfies SEBI’s mandatory reporting requirements for substantial share‑acquisitions by promoters. By increasing its stake to 49.40 %, Mikusu India Private Ltd solidifies its position as the dominant shareholder, but the filing does not indicate any change in control or a shift in the promoter group’s intent. The transaction was executed in the open market, meaning no new shares were issued and the company’s capital structure remains unchanged.

For shareholders, the key implications are:

• Transparency: The filing provides a clear, regulator‑mandated record of the promoter’s incremental purchase.
• Dilution: There is no dilution of existing shareholders because the shares were bought from the market, not issued anew.
• Control: The promoter’s stake remains just shy of the 50 % threshold that would constitute outright majority control; however, at 49.40 % the promoter already wields significant voting power.
• Regulatory compliance: The filing confirms that the promoter has complied with SEBI’s takeover code, reducing the risk of future regulatory surprises.

Investors should monitor any subsequent disclosures that might indicate further share purchases, disposals, or changes in the promoter group’s composition, as these could affect voting dynamics and corporate governance.

Conclusion

Mikusu India Private Ltd’s open‑market purchase of 5,040 shares on 15 June 2026 raised its holding in Daikaffil Chemicals India Ltd to 49.40 % of the total share capital. The transaction was disclosed in compliance with SEBI Regulation 29(2) on 16 June 2026 and does not alter the company’s capital structure. While the promoter’s stake is now marginally higher, no change in control is reported, and the filing completes the required regulatory notification for this acquisition.